amikacin has been researched along with Alloxan Diabetes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| El-Naggar, MY; Gohar, YM; Sorour, MA; Waheeb, MG | 1 |
| Hirose, T; Kumamoto, Y; Tanaka, N; Yokoo, A | 1 |
| El-Sherbiny, M; Helal, MG; Said, E; Salem, HA; Samaha, MM | 1 |
| Abdel-Rahman, AA; Leffler, KE | 1 |
| Byeon, S; Choi, SK; Haam, CE; Kwon, Y; Lee, YH | 1 |
| Albaladejo-Otón, MD; Arnao, MB; Gázquez, A; Larqué, E; Martínez-Gascón, LE; Rodríguez, F; Sánchez-Campillo, M; Saura-Garre, P | 1 |
| Christie, BR; Komal, P; Lee, TH; Lin, K; Siu, PM; So, KF; Xu, A; Yau, SY; Yuan, TF; Zhang, L | 1 |
| Du, Y; Gan, L; Gao, E; Guo, R; Koch, W; Lau, WB; Liang, B; Ma, XL; Wang, Y; Yan, W; Yan, Z; Zhao, J | 1 |
| Hu, M; Huang, W; Li, J; Ma, X; Wang, X; Wang, Y; Xu, Q; Zhu, P | 1 |
| Li, CX; Lv, JP; Qu, XH; Shi, Y; Xiao, M; Xie, KJ | 1 |
| Cai, QJ; Chen, H; Qu, XH; Xiao, M; Xie, KJ | 1 |
| Chen, H; Huang, L; Qu, XH; Xiao, M; Xie, KJ | 1 |
| Huang, L; Li, X; Qu, XH; Wang, SJ; Xiao, M; Xie, KJ | 1 |
| Holland, WL; Scherer, PE | 1 |
14 other study(ies) available for amikacin and Alloxan Diabetes
| Article | Year |
|---|---|
Hydrogel Dressing with a Nano-Formula against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Diabetic Foot Bacteria.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Artemia; Bacteria; Bandages, Hydrocolloid; Chitosan; Coinfection; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Metal Nanoparticles; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rats; Silver; Staphylococcus aureus; Wound Healing | 2016 |
[Study of the increasing effect of therapeutic efficacy of amikacin in combination with human granulocyte-colony stimulating factor (G-CSF) against experimental urinary tract infection in diabetic mice].
Topics: Amikacin; Animals; Anti-Infective Agents, Urinary; Diabetes Mellitus, Experimental; Drug Evaluation; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Mice; Mice, Inbred Strains; Pseudomonas Infections; Urinary Tract Infections | 1991 |
Diacerein versus adipoRon as adiponectin modulators in experimentally-induced end-stage type 2 diabetes mellitus in rats.
Topics: Adiponectin; Adipose Tissue; Animals; Anthraquinones; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Male; Muscle, Skeletal; Piperidines; Rats, Sprague-Dawley | 2022 |
Restoration of Adiponectin-Connexin43 Signaling Mitigates Myocardial Inflammation and Dysfunction in Diabetic Female Rats.
Topics: Adiponectin; Animals; Arginine; Connexin 43; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Estradiol; Estrogen Receptor alpha; Female; Heme Oxygenase (Decyclizing); Hypertrophy, Left Ventricular; Ovariectomy; Piperidines; Rats, Wistar; Receptors, Adiponectin; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2020 |
AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelium, Vascular; Insulin Resistance; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; Nitric Oxide Synthase Type III; Phosphorylation; Piperidines; Receptors, Adiponectin | 2020 |
Adiponectin agonist treatment in diabetic pregnant rats.
Topics: Adiponectin; Adiposity; Animals; Birth Weight; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes, Gestational; Female; Male; Oxidative Stress; Piperidines; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats | 2021 |
Chronic AdipoRon Treatment Mimics the Effects of Physical Exercise on Restoring Hippocampal Neuroplasticity in Diabetic Mice.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Dendritic Spines; Diabetes Mellitus, Experimental; Hippocampus; Mice; Neurogenesis; Neuronal Plasticity; Phosphorylation; Physical Conditioning, Animal; Piperidines; Spatial Memory | 2021 |
Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Autophagosomes; Autophagy; Beclin-1; Cells, Cultured; Diabetes Mellitus, Experimental; Lysosomal-Associated Membrane Protein 2; Metalloporphyrins; Mice; Mice, Knockout; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphorylation; Piperidines; Receptors, Adiponectin | 2017 |
Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Chalcones; Cholesterol; Diabetes Mellitus, Experimental; Drug Design; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Piperidines; PPAR alpha; Receptors, Adiponectin; Triglycerides | 2018 |
[AdipoRon for the treatment of type 2 diabetes in mice and its possible mechanism of the liver].
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Liver; Male; Mice; Mice, Inbred C57BL; Piperidines | 2016 |
[Intervention effects of oral active AdipoRon on liver oxidative stress in type 2 diabetic mice].
Topics: Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidative Stress; Piperidines; Receptors, Adiponectin; Superoxide Dismutase | 2017 |
[The intervention effects of AdipoRon on renal injury in type 2 diabetic mice].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Kidney; Male; Mice; Piperidines | 2018 |
[Effects of AdipoRon orally on the functions of spleen and pancreas in type 2 diabetic mice].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Insulin; Insulin Receptor Substrate Proteins; Male; Mice; Pancreas; Piperidines; Random Allocation; Receptor, Insulin; Spleen | 2019 |
Cell Biology. Ronning after the adiponectin receptors.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Apoptosis; Ceramidases; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoglycemic Agents; Insulin Resistance; Mice; Molecular Mimicry; Molecular Targeted Therapy; Obesity; Piperidines; Receptors, Adiponectin | 2013 |